AMGN|Amgen Inc|가격:353.280|Chg%:1.43

자세한 내용은 Amgen Inc 회사

Amgen Inc. is a biotechnology company. It discovers, develops, manufactures and delivers medicines for the toughest diseases. It focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve people’s lives. It operates in the human therapeutics segment. Its marketed products portfolio includes EPOGEN (epoetin alfa); Aranesp (darbepoetin alfa); Parsabiv (etelcalcetide); Neulasta (pegfilgrastim); KANJINTI (trastuzumab-anns); Otezla; BLINCYTO (blinatumomab); ACTIMMUNE (interferon gamma-1b); Neulasta (pegfilgrastim); Sensipar/Mimpara (cinacalcet); Prolia (denosumab); ENBREL; QUINSAIR (levofloxacin); Repatha (evolocumab) and others. It markets ENBREL, a tumor necrosis factor blocker, in the United States and Canada. It markets Otezla, a small molecule that inhibits phosphodiesterase 4, in many countries around the world. It markets Repatha, a proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor, in many countries around the world.

Amgen Inc 정보



종목 코드 AMGN

회사 이름Amgen Inc

상장일Jun 17, 1983

CEOBradway (Robert A)

직원 수28000

유형Ordinary Share

회계 연도 종료Jun 17

주소One Amgen Center Drive

도시THOUSAND OAKS

증권 거래소NASDAQ OMX - NASDAQ BASIC

국가United States of America

우편 번호91320-1799

전화18054471000

웹사이트https://www.amgen.com/

종목 코드 AMGN

상장일Jun 17, 1983

CEOBradway (Robert A)

Amgen Inc의 회사 임원진



이름

이름/직위

직위

주식 보유

변동

Mr. Robert A. (Bob) Bradway

Chairman of the Board, President, Chief Executive Officer

623.23K

+9.12%

Mr. Esteban Santos

Executive Vice President - Operations

74.69K

+7.55%

Mr. Murdo Gordon

Executive Vice President - Global Commercial Operations

41.53K

+16.16%

Dr. Tyler Jacks

Independent Director

17.19K

+4.71%

Mr. Derek Miller

Senior Vice President - Human Resources

11.80K

+15.84%

Ms. Rachna Khosla

Senior Vice President - Business Development

7.83K

+14.93%

Dr. Brian J. Druker, M.D.

Independent Director

7.57K

+10.69%

Dr. Wanda M. Austin, Ph.D.

Independent Director

7.35K

+11.00%

Ms. Nancy A. Grygiel

Senior Vice President, Chief Compliance Officer

7.26K

+16.85%

Dr. Michael V. Drake, M.D.

Independent Director

4.89K

+4.48%

이름

이름/직위

직위

주식 보유

변동

Mr. Robert A. (Bob) Bradway

Chairman of the Board, President, Chief Executive Officer

623.23K

+9.12%

Mr. Esteban Santos

Executive Vice President - Operations

74.69K

+7.55%

Mr. Murdo Gordon

Executive Vice President - Global Commercial Operations

41.53K

+16.16%

Dr. Tyler Jacks

Independent Director

17.19K

+4.71%

Mr. Derek Miller

Senior Vice President - Human Resources

11.80K

+15.84%

Ms. Rachna Khosla

Senior Vice President - Business Development

7.83K

+14.93%

수익 분석

통화: USD마지막 업데이트: Tue, Jan 6

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

사업별USD

이름

수익

비율

Other products

1.85B

19.39%

Prolia

1.14B

11.92%

Repatha

794.00M

8.31%

Otezla

585.00M

6.12%

Enbrel

580.00M

6.07%

기타

4.61B

48.20%

지역별USD

이름

수익

비율

US

6.33B

66.28%

ROW

2.26B

23.67%

사업별

지역별

사업별USD

이름

수익

비율

Other products

1.85B

19.39%

Prolia

1.14B

11.92%

Repatha

794.00M

8.31%

Otezla

585.00M

6.12%

Enbrel

580.00M

6.07%

기타

4.61B

48.20%

주식 보유 통계

마지막 업데이트: Thu, Feb 19

주주

주주 유형

주주

비율

The Vanguard Group, Inc.

10.12%

State Street Investment Management (US)

5.67%

BlackRock Institutional Trust Company, N.A.

5.49%

Capital World Investors

4.28%

Capital International Investors

3.37%

기타

71.05%

주주

비율

The Vanguard Group, Inc.

10.12%

State Street Investment Management (US)

5.67%

BlackRock Institutional Trust Company, N.A.

5.49%

Capital World Investors

4.28%

Capital International Investors

3.37%

기타

71.05%

주주 유형

주주

비율

Investment Advisor

54.38%

Investment Advisor/Hedge Fund

19.70%

Research Firm

4.54%

Pension Fund

2.24%

Bank and Trust

1.85%

Sovereign Wealth Fund

1.28%

Hedge Fund

0.65%

Insurance Company

0.60%

Individual Investor

0.18%

기타

14.58%

기관 주식 보유



마지막 업데이트: Wed, Apr 1

보고 기간

기관 수

보유 주식

비율

변동

2026Q1

4571

459.62M

85.26%

+2.87M

2025Q4

4407

451.47M

85.20%

+63.91K

2025Q3

4486

451.61M

85.29%

-1.24M

2025Q2

4487

452.85M

84.91%

+2.52M

2025Q1

4500

450.78M

83.12%

+3.88M

2024Q4

4470

440.57M

82.15%

+6.55M

2024Q3

4290

435.41M

82.39%

-1.01M

2024Q2

4260

436.06M

82.34%

+1.04M

2024Q1

4169

435.45M

81.98%

-3.93M

2023Q4

4130

433.32M

81.14%

+5.55M

주주 활동



이름

보유 주식

비율

변동

Chg %

날짜

The Vanguard Group, Inc.

53.62M

9.96%

-236.61K

-0.44%

Sep 30, 2025

State Street Investment Management (US)

29.30M

5.44%

-52.93K

-0.18%

Sep 30, 2025

BlackRock Institutional Trust Company, N.A.

28.53M

5.3%

-304.25K

-1.06%

Sep 30, 2025

Capital World Investors

18.80M

3.49%

+1.94M

+11.48%

Sep 30, 2025

Capital International Investors

19.19M

3.56%

+282.22K

+1.49%

Sep 30, 2025

Geode Capital Management, L.L.C.

13.27M

2.46%

+248.90K

+1.91%

Sep 30, 2025

Charles Schwab Investment Management, Inc.

13.55M

2.52%

+656.93K

+5.10%

Sep 30, 2025

Invesco Capital Management (QQQ Trust)

12.08M

2.24%

+795.62K

+7.05%

Dec 31, 2025

Morgan Stanley Smith Barney LLC

8.89M

1.65%

+77.14K

+0.87%

Sep 30, 2025

PRIMECAP Management Company

9.71M

1.8%

-924.10K

-8.69%

Sep 30, 2025

주식 배당금



지난 5년 동안 총 17.60B USD의 배당금이 분배되었습니다.

날짜

배당금

기준일

지급일

배당락일

Dec 09, 2025

AMGN.NB Interim Cash Dividend of gross USD 2.52 paid on Mar 06, 2026 going ex on Feb 13, 2026

Feb 13, 2026

Mar 06, 2026

Feb 13, 2026

Oct 31, 2025

AMGN.NB Final Cash Dividend of gross USD 2.38 paid on Dec 12, 2025 going ex on Nov 21, 2025

Nov 21, 2025

Dec 12, 2025

Nov 21, 2025

Aug 01, 2025

AMGN.NB Interim Cash Dividend of gross USD 2.38 paid on Sep 12, 2025 going ex on Aug 22, 2025

Aug 22, 2025

Sep 12, 2025

Aug 22, 2025

Mar 04, 2025

AMGN.NB Interim Cash Dividend of gross USD 2.38 paid on Jun 06, 2025 going ex on May 16, 2025

May 16, 2025

Jun 06, 2025

May 16, 2025

Dec 10, 2024

AMGN.NB Interim Cash Dividend of gross USD 2.38 paid on Mar 07, 2025 going ex on Feb 14, 2025

Feb 14, 2025

Mar 07, 2025

Feb 14, 2025

Oct 25, 2024

AMGN.NB Final Cash Dividend of gross USD 2.25 paid on Dec 09, 2024 going ex on Nov 18, 2024

Nov 18, 2024

Dec 09, 2024

Nov 18, 2024

Aug 02, 2024

AMGN.NB Interim Cash Dividend of gross USD 2.25 paid on Sep 06, 2024 going ex on Aug 16, 2024

Aug 16, 2024

Sep 06, 2024

Aug 16, 2024

Mar 06, 2024

AMGN.NB Interim Cash Dividend of gross USD 2.25 paid on Jun 07, 2024 going ex on May 16, 2024

May 17, 2024

Jun 07, 2024

May 16, 2024

Dec 12, 2023

AMGN.NB Interim Cash Dividend of gross USD 2.25 paid on Mar 07, 2024 going ex on Feb 15, 2024

Feb 16, 2024

Mar 07, 2024

Feb 15, 2024

Oct 24, 2023

AMGN.NB Final Cash Dividend of gross USD 2.13 paid on Dec 08, 2023 going ex on Nov 16, 2023

Nov 17, 2023

Dec 08, 2023

Nov 16, 2023

주식 분할



날짜

배당락일

유형

비율

데이터 없음

날짜

배당락일

유형

비율

데이터 없음

Amgen Inc

자세한 내용은 Amgen Inc 회사

Amgen Inc 정보

Amgen Inc의 회사 임원진

수익 분석

주식 보유 통계

기관 주식 보유

주주 활동

관련 ETF

주식 배당금

주식 분할